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1. Introduction 2. Materials and methods 
A corticotropin$-lipotropin (ACTHQ-LPH) pre- 
cursor consists of 239 amino acid residues [I] and its 
amino acid sequence contains three repetitive His- 
Phe-Arg-Trp sequences, in the (Y-, p- and y-MSH 
regions, corresponding to positions Ill- 114, 197- 
200 and 55-58, respectively. Proteolytic processing of 
this precursor generates everal biologically active 
peptides with corticotropic, lipolytic or melanotropic 
activity [2,3]. The N-terminal part of the precursor 
molecule (pro-y-MSH), remaining after the cleavages 
that remove ACTH and /3-LPH, consists of 103 amino 
acid residues [1,4] and contains the y-MSH sequence. 
Little is known about the processing of pro-y-MSH 
[5,6]. The same is true for the biological significance 
of this molecule or for that of -y-MSH. We now 
describe the purification and primary structure of a 
pro-T-MSH fragment, which appears to comprise the 
first 30 residues of the precursor. This fragment results 
from proteolysis at an unexpected site in the promol- 
ecule. The sequence shows a substrate specificity for 
the protease involved that suggests the enzyme to 
resemble enzymes cleaving nascent pre-promolecules 
rather than those cleaving at dibasic structures in pro- 
molecules [7 81. 
On the whole, the sequence results confirm the 
partial N-terminal amino acid sequence for porcine 
pro?-MSH proposed in [4]. In addition, they establish 
two positions with previously unidentified residues, 
correct a misidentification and show the occurrence 
of different partial desamidations. 
The starting material was 1 kg frozen pig pituitar- 
ies, extracted and purified by chromatography on an 
anionexchange column (DEAE-Sephadex) as describec 
in [4]. The fractions were analyzed fluorimetrically 
for peptides with N-terminal tryptophan [9]. These 
were eluted from the column by raising the ionic 
strength, as in [4]. The material was then dialyzed and 
freezedried. Portions of 1 g were passed through a 
carboxymethyl-cellulose column (2.6 X 7 cm), equil- 
ibrated with 0.02 M sodium acetate buffer (pH 3.5). 
After elution of non-adsorbed material, the pH was 
raised to 8.5 (0.02 M phosphate buffer). The material 
recovered at this pH was rich in peptides with N-ter- 
minal tryptophan. Following dialysis, it was freeze- 
dried and passed through a Sephadex G-75 column 
(0.9 X 6 cm). The material thus obtained was purified 
to homogeneity by preparative high-performance 
liquid chromatography (Waters instrument, 6600 A 
solvent delivery system, UK injector, model 450 vari- 
able wavelength detector) using a 30 X 0.78 cm 
PBondapak Cl8 column. Acetonitrile/O.l M ammo- 
nium acetate (pH 4.5) (35:65, v/v) was used as eluant 
and the absorbance was monitored at 280/206 nm. 
The homogeneity of the final product was established 
by analytical high-performance liquid chromatography 
using a 30 X 0.39 cm PBondapak C,s column and the 
same procedure as above. 
? To whom correspondence should be addressed 
Amino acid compositions were determined with a 
Beckman 121 M instrument after hydrolysis at 110°C 
for 22 h with 6 M HCl/O.S% phenol, in evacuated 
tubes. Hydrazinolysis was performed for 6 h at 1 lO”C, 
and the result was determined both by direct applica- 
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tion to the amino acid analyzer and by dansylation and 
subsequent identification of dansyl ammo acids [lo]. 
Sequential degradations were carried out in a 
Beckman 890 C liquid-phase sequencer, using a 0.1 M 
Quadrol program in the presence of Polybrene, added 
together with glycine and precycled as in [ 111. Phenyl- 
thiohydantoin derivatives were identified by high-per- 
formance liquid chromatography in a Hewlett-Packard 
1084B instrument on a Nucleosil C ,a column using an 
acetate/acetonitrile system, and by thin-layer chroma- 
tography and subsequent ninhydrin staining [ 111. 
Cysteine/half-cystine residues were identified by 
14C-measurements during degradation of a ‘%Z-car- 
boxymethylated sample that had been prepared by sub- 
mitting the peptide (40 nmol) in 6 M guanidine-HCl, 
0.1 M Tris-HCl, 2 mM EDTA (pH 8.2) to reduction 
with dithiothreitol(2.5 pmol) for 2 h at 37”C, treat- 
ment with iodo [2-14C]acetate (7.5 pmol; 3000 dpm/ 
nmol) for 1 h at 37”C, and removal of reagents by 
dialysis against distilled water in Spectrapor 3 tubing 
(Spectrum Medical Co., Los Angeles CA). 
3. Results 
3 .l . Purity and composition 
A peptide fraction was prepared from porcine pitu- 
itaries by two ion-exchange chromatography steps fol- 
lowed by gel chromatography. The material from the 
latter step was still heterogeneous but was purified to 
a homogeneous product by high performance liquid 
chromatography as illustrated in fig.1. Identification 
of tryptophan as the only N-terminal residue, the 
composition (below), and the results of amino acid 
sequence analysis (below) further show the purity. 
The amino acid composition, given in table 1, fits 
residues I-30 of the pro-y-MSH molecule [ 1,4] and 
suggests that the peptide constitutes that fragment. 
3 2. Amino acid sequence 
The amino acid sequence was elucidated by degra- 
dations in a liquid-phase sequencer. The results are 
shown in fig.2. On the whole, earlier data [4] regard- 
ing the first 30 residues of the pro-y-MSH molecule 
were confirmed. Two residues previously missing 
(positions 15 and 25) were established (cf. fig.2). Fur- 
thermore, a misidentified position was also corrected: 
Glu in position 4. Partial desamidations were detected 
(cf. fig.%), in particular in position 10. The high yield 
of aspartic acid, and the identification of that residue 
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Fig.1. High-performance liquid chromatography of material 
obtained from Sephadex gel chromatography (cf. text). 
(A) Elution profile on a preparative PBondapak C,, column: 
flow rate 2 ml/min, with collection of 2 ml fractions. (B) 
Rechromatography on an analytical PBondapak C,, column 
of the peptide containing N-terminal tryptophan, correspond- 
ing to the peak designated Trp in (A). 
[4] might even question the conclusion of asparagine 
in this position, although the amide assignment is the 
likely alternative (fig .2). 
The composition and the sequence degradation sug, 
gest that the peptide ends with Ala-30. Analysis by 
hydrazinolysis confirmed the presence of C-terminal 
alanine. However, the results also indicated the pres- 
ence of small amounts of glutamic acid and threonine. 
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Table 1 
Ammo acid composition of the investigated fragment of 
pro-y-MSH 
Residue 
_____~ 
Cys 
Asx 
Thr 
Ser 
Glx 
Pro 
Ala 
lie 
Leu 
TIP 
Lys 
Arg 
Sum 
Amount 
1.4 (4) 
3.0 (3) 
1 .o (1) 
4.3 (5) 
4.0 (4) 
1.3 (1) 
2.1 (3) 
0.8 (1) 
4.8 (5) 
0.2 (1) 
0.9 (1) 
0.8 (1) 
30 
Duplicate samples of the non-modified peptide were hydro- 
lyzed at 110°C for 22 h with 6 M HC1/0.5% phenol in evacu- 
ated tubes, explaining the low yield of Cys, Ser and Trp. Anal- 
ytical values are molar ratios without corrections for destruc- 
tion, slow release or impurities. The number of residues from 
the sequence analysis is shown within parentheses 
Interestingly, these very residues occur subsequent o 
Ala-30 in the pro-y-MSH molecule. Some minor het- 
erogeneity in the C-terminus can therefore not be 
excluded, but the C-terminus at Ala-30 is consistent 
with the composition (table l), the hydrazinolysis 
and the sequencer degradation (fig.2). 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Trp-Cys-Leu-Glu-Ser-Ser-Gln-Cys-Gln-Asn-Leu-Ser-Thr-Glu-Ser- 
H,T R H,T H,T H,T H,T H,T R H,T H,T H,T H,T H,T H,T H,T 
60 50 
(Glu) (Glu)(Asp) 
(15%) (30$(50%) 
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
-Asn-Leu-Leu-Ala-Cys-Ile-Arg-Ala-Cys-Lys-Pro-Asp-Leu-Ser-Ala. 
H,T H,T H,T H,T R H,T H H,T R H,T H,T H,T H,T H,T H,T 
35 40 35 25 25 15 <5 
Fig.2. Ammo acid sequence of the investigated fragment of 
pro-y-MSH. The structure was determined by sequencer degra- 
dations of the intact peptide (-300 nmol) and of the *?Z-car- 
boxymethylated peptide (-40 nmol). Residue identifications 
by high-performance liquid chromatography (H), and thin- 
layer chromatography (T) from analysis of the intact peptide 
(initial coupling 60%; values give the yield in % for the stable 
residues; repetitive yield Leu3,,,: 96%), and by 14C-radio- 
activity (R) for the analysis of the carboxymethylated pep- 
tide. Extensive desamidation was noticed for residue 10, and 
some amide losses were also encountered for residues 7,9 
and 16, as indicated. 
From the structure of pro?-MSH, there is no pre- 
dictable cleavage site explaining its C-terminus. The 
l-30 fragment must therefore have been generated by 
a cleavage at a site different from the traditional pro- 
hormone cleavage sites at paired basic residues [7,8]. 
4. Discussion 
4 .l . Structure of pro-y-MSH 
The complete structure of bovine pro-y-MSH had 
been deduced from determination of the mRNA- 
coded cDNA [ 11, and a partial structure of porcine 
pro-y-MSH obtained from a protein sequence analysis 
[4]. This partial sequence is now corrected and con- 
firmed by final assignments of residues in positions 4, 
15,2.5 and possibly 10, as shown in fig.2. Compari- 
sons between the structures in fig.2 and [l], show 
that the porcine pro-y-MSH differs from its bovine 
counterpart in only a few positions. Position 10 has a 
probable Asp/Asn exchange (the occurrence of exten- 
sive desamidations still question the amide), and posi- 
tion 12 has a definite Thr/Ser exchange. 
4.2. New type of pro teoly tic processing 
The structure in fig.2 does not end in a pair of 
basic residues. Nor are any such residues found in the 
immediate proximity inside the prey-MSH molecule. 
The closest base pair is 19 residues further away [l] 
towards the C-terminus of the pro-form. Since it is 
unlikely that so many residues are removed by exo- 
protease processing after an initial endoprotease 
cleavage, it can be concluded that the fragment now 
characterized is generated by a direct endoprotease 
cleavage at a site lacking the traditional dibasic struc- 
ture. This cleavage site is therefore different from the 
other known cleavage sites in the ACTHQ-LPH precur- 
sor, where 10 dibasic structures occur [l]. In contrast, 
the substrate specificity of the protease generating the 
present fragment appears more related to those of the 
proteases hydrolysing nascent pre-promolecules, like 
the Gly-Trp cleavage involved in generating the 
ACTHP-LPH precursor [l] or the Ala-cleavages that 
frequently produce the C-terminal ends of signal 
sequences [ 121. 
The finding of a new small pro-T-MSH fragment 
explains other data. Thus, several smaller pro-y-MSH- 
related peptides in extracts of porcine pituitaries have 
been found by the use of a gel permeation system and 
a radioimmunoassay for pror-MSH [ 131. One of 
these pro?-MSH-related peptides eluted at a position 
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similar to that of Pendorphin, suggesting MI - 3500, 
close to that expected for the present l-30 fragment 
(M, 3281). 
Whether the l-30 peptide is a normally occurring 
fragment of proT-MSH, and whether it exists in the 
ACTH or the MSH cells or in both remains to be 
established. In any event, these results define a new 
cleavage site, and establish the structure of the N-ter- 
minal part of this porcine pro-y-MSH. 
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